Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Autoimmune Features of Neurodegenerative Disorders

Authors not listed

Columbia University · 2019

Abstract

This study is being conducted to better understand the role of inflammation in Parkinson's disease (PD) and Alzheimer's disease (AD). The investigators plan to recruit 30 PD, 30 AD/Amnestic Mild Cognitive Impairment (aMCI), and 60 age matched healthy controls in this study to study the role of immune response in PD and AD. The study involves up to two study visits involving brief questionnaires and blood draw of up to 250cc (approximately 17 tablespoons) to be collected. More ways to participate, including 1) smaller amount blood donation (up to 100cc per visit for 1-2 visits); and 2) participation via tele-visit and mobile phlebotomy visits (blood donation up to 50cc, \~5 tubes, by a certified mobile phlebotomist at home/location of choice) now available.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-08 MST

Cite this

APA
Anonymous. (2019). Autoimmune Features of Neurodegenerative Disorders. <em>Columbia University</em>. https://clinicaltrials.gov/study/NCT04239079
Vancouver
Anonymous. Autoimmune Features of Neurodegenerative Disorders. Columbia University. 2019.
BibTeX
@misc{anon2019Autoim, title = {Autoimmune Features of Neurodegenerative Disorders}, author = {Anonymous}, journal = {Columbia University}, year = {2019}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings